Ensign Peak Advisors, Inc Aurinia Pharmaceuticals Inc. Transaction History

Ensign Peak Advisors, Inc

$51.2 Billion
Q1 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 63,735 shares of AUPH stock, worth $723,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,735

Previous 63,735 -0.0%

Holding current value

$723,392

Previous $572,000 10.49%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$4.93 - $9.31 $15,849 - $29,931	-3,215 Reduced 4.8%	63,735 $319,000
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $127,270 - $169,396	17,850 Added 36.35%	66,950 $601,000
Q3 2023 Nov 13, 2023	BUY	$7.77 - $12.27 $106,060 - $167,485	13,650 Added 38.5%	49,100 $381,000
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $317,632 - $414,410	35,450 New	35,450 $343,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $49,550 - $92,181	7,440 Added 22.75%	40,150 $302,000
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $16,482 - $36,867	1,640 Added 5.28%	32,710 $405,000
Q4 2021 Feb 11, 2022	SELL	$17.78 - $33.08 $1.78 Million - $3.31 Million	-100,133 Reduced 76.32%	31,070 $711,000
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $222,928 - $480,325	-20,396 Reduced 13.45%	131,203 $2.9 Million
Q2 2021 Aug 13, 2021	BUY	$10.0 - $14.52 $505,400 - $733,840	50,540 Added 50.01%	151,599 $1.97 Million
Q1 2021 May 12, 2021	BUY	$12.3 - $18.73 $94,734 - $144,258	7,702 Added 8.25%	101,059 $1.31 Million
Q4 2020 Feb 12, 2021	BUY	$12.94 - $16.05 $321,326 - $398,553	24,832 Added 36.24%	93,357 $1.29 Million
Q3 2020 Nov 12, 2020	BUY	$13.19 - $16.66 $697,381 - $880,847	52,872 Added 337.78%	68,525 $1.01 Million
Q2 2020 Aug 12, 2020	BUY	$14.12 - $18.33 $221,020 - $286,919	15,653 New	15,653 $254,000

Others Institutions Holding AUPH

# of Institutions

243

Shares Held

62.4M

Call Options Held

1.03M

Put Options Held

666K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.61B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Aurinia Pharmaceuticals Inc. Transaction History